These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36660044)
41. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888 [TBL] [Abstract][Full Text] [Related]
42. Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC. Shao H; Zhang Y; Yan J; Ban X; Fan X; Chang X; Lu Z; Wu Y; Zong L; Mo S; Yu S; Chen J Onco Targets Ther; 2021; 14():2163-2175. PubMed ID: 33790579 [TBL] [Abstract][Full Text] [Related]
43. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
44. Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma. Cao D; Cao X; Jiang Y; Xu J; Zheng Y; Kang D; Xu C Hematol Oncol; 2022 Apr; 40(2):172-180. PubMed ID: 34874565 [TBL] [Abstract][Full Text] [Related]
45. Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke. Li DB; Liu JL; Wang W; Li RY; Yu DJ; Lan XY; Li JP Curr Neurovasc Res; 2017; 14(4):330-337. PubMed ID: 28982331 [TBL] [Abstract][Full Text] [Related]
46. Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Faur CI; Rotaru H; Osan C; Jurj A; Roman RC; Moldovan M; Chirila M; Hedesiu M Maxillofac Plast Reconstr Surg; 2021 Jun; 43(1):19. PubMed ID: 34191144 [TBL] [Abstract][Full Text] [Related]
47. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Kitagawa T; Taniuchi K; Tsuboi M; Sakaguchi M; Kohsaki T; Okabayashi T; Saibara T Mol Oncol; 2019 Feb; 13(2):212-227. PubMed ID: 30358104 [TBL] [Abstract][Full Text] [Related]
48. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies. Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
50. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750 [TBL] [Abstract][Full Text] [Related]
51. Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer. Wu L; Zhou WB; Zhou J; Wei Y; Wang HM; Liu XD; Chen XC; Wang W; Ye L; Yao LC; Chen QH; Tang ZG Oncol Lett; 2020 Aug; 20(2):1432-1440. PubMed ID: 32724386 [TBL] [Abstract][Full Text] [Related]
52. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108 [TBL] [Abstract][Full Text] [Related]
53. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Shang S; Wang J; Chen S; Tian R; Zeng H; Wang L; Xia M; Zhu H; Zuo C Cancer Med; 2019 Dec; 8(18):7728-7740. PubMed ID: 31642612 [TBL] [Abstract][Full Text] [Related]
54. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577 [TBL] [Abstract][Full Text] [Related]
55. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. Ganepola GA; Rutledge JR; Suman P; Yiengpruksawan A; Chang DH World J Gastrointest Oncol; 2014 Jan; 6(1):22-33. PubMed ID: 24578785 [TBL] [Abstract][Full Text] [Related]
56. Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer. Wang S; Song X; Wang K; Zheng B; Lin Q; Yu M; Xie L; Chen L; Song X Front Oncol; 2022; 12():986343. PubMed ID: 36591520 [TBL] [Abstract][Full Text] [Related]
57. Exosomal miR-23a and miR-192, Potential Diagnostic Biomarkers for Type 2 Diabetes. Liu C; Gao Y; Wu J; Zou J Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616347 [TBL] [Abstract][Full Text] [Related]
58. Serum-Derived Exosomal miR-140-5p as a Promising Biomarker for Differential Diagnosis of Anti-NMDAR Encephalitis With Viral Encephalitis. Liu X; Fan K; Lin Q; Tang M; Wang Q; Huang E; Zhang W; Chen T; Ou Q Front Immunol; 2022; 13():840003. PubMed ID: 35273615 [TBL] [Abstract][Full Text] [Related]
59. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
60. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]